EAM Investors’s Bioventus BVS Stock Holding History

EAM Investors’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75,199	Closed	-$899K	–	270
2024 Q3	$899K	Sell	75,199 -36,069	-32%	-$312K	0.13%	173
2024 Q2	$640K	Buy	+111,268	New	+$610K	0.1%	211

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

EAM Investors's BVS Position: Q4 2024 in Review

EAM Investors sold out of Bioventus (BVS) in Q4 2024, closing a stake of 75,199 shares — an estimated $899K sold.

EAM Investors first reported a position in BVS in Q2 2024 and held it in 2 quarters. The position peaked at $899K in Q3 2024. 151 funds tracked by Wall St. Rank hold BVS as of Q4 2024.

EAM Investors reported no remaining Bioventus position as of Q4 2024 after selling out during the quarter.
EAM Investors sold 75,199 Bioventus shares in Q4 2024, an estimated $899K.
EAM Investors first reported a position in Bioventus in Q2 2024 and held it in 2 quarters.
EAM Investors's Bioventus position peaked at $899K in Q3 2024.
151 funds tracked by Wall St. Rank held Bioventus as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.